Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Indiana University Center for Health Innovation and Implementation Science, Sandra Eskenazi Center for Brain Care Innovation, Indianapolis, IN, USA.
Alzheimers Dement. 2016 Mar;12(3):334-69. doi: 10.1016/j.jalz.2016.01.005. Epub 2016 Feb 8.
Under the U.S. national Alzheimer's plan, the National Institutes of Health identified milestones required to meet the plan's biomedical research goal (Goal 1). However, similar milestones have not been created for the goals on care (Goal 2) and support (Goal 3).
The Alzheimer's Association convened a workgroup with expertise in clinical care, long-term services and supports, dementia care and support research, and public policy. The workgroup reviewed the literature on Alzheimer's care and support; reviewed how other countries are addressing the issue; and identified public policies needed over the next 10 years to achieve a more ideal care and support system.
The workgroup developed and recommended 73 milestones for Goal 2 and 56 milestones for Goal 3.
To advance the implementation of the U.S. national Alzheimer's plan, the U.S. government should adopt these recommended milestones, or develop similar milestones, to be incorporated into the national plan.
根据美国国家阿尔茨海默病计划，美国国立卫生研究院确定了实现该计划生物医学研究目标（目标 1）所需的里程碑。然而，针对护理（目标 2）和支持（目标 3）目标，尚未制定类似的里程碑。
阿尔茨海默病协会召集了一个工作组，成员在临床护理、长期服务和支持、痴呆症护理和支持研究以及公共政策方面具有专业知识。工作组审查了关于阿尔茨海默病护理和支持的文献；审查了其他国家如何解决这个问题；并确定了未来 10 年实现更理想的护理和支持系统所需的公共政策。
工作组为目标 2 制定并推荐了 73 个里程碑，为目标 3 制定并推荐了 56 个里程碑。
为了推进美国国家阿尔茨海默病计划的实施，美国政府应采纳这些建议的里程碑，或制定类似的里程碑，纳入国家计划。
